The Board of Directors of Sanofi SA has decided not to renew Paul Hudson’s mandate as chief executive after six years of leadership and to appoint Belén Garijo to the role effective 29 April. This the date of the company’s annual general meeting. Dr Garijo was an executive at Sanofi for 15 years before moving to Merck KGaA in 2011 as chief operating officer and then progressing to the position of CEO in 2021. At the Sanofi AGM, she will be nominated as a group director in addition to her upcoming role as CEO.
